We are studying a new treatment for kidney transplant recipients facing antibody-mediated rejection. The trial aims to evaluate the safety and how well this medication works compared to a placebo.
Health conditions and diseases that the clinical trial is designed to study and treat.
Antibody-Mediated Rejection (AMR) is a condition that occurs when the immune system produces antibodies against transplanted organs or tissues, leading to inflammation and damage. This can result in symptoms such as organ dysfunction and may require medical intervention.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
